IV
Integra Ventures
Venture CapitalActiveIntegra Ventures seek investments in Life Science companies in three principal areas: Drug Development, Medical Devices, and Healthcare
Seattle, United StatesFounded 2006
15
Investments
5
Exits
$100M
AUM
33.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Integra Ventures.
Investment Thesis & Strategy
Integra Ventures invests in early to late-stage Life Science companies, specifically in drug development, medical devices, and healthcare. They focus on companies with innovative solutions and strong growth potential.
Investment Activity
Deals per year over the last 3 years
1
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 15 companies
A
Aegle Therapeutics
Biotech · Series B, 2023
A
Aegle Therapeutics
Biotech · Series A, 2021
Notable Exits
CompanyTypeYearValue / Acquirer
Coda PaymentsAcquisition2023—
CarousellIPO2023—
KumuAcquisition2023—
Pomelo FashionAcquisition2022—
PayfazzAcquisition2021—
Frequently Asked Questions
Integra Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Madrona Venture Group
Seattle, United States · 359 deals
Vulcan Capital
Seattle, United States · 194 deals
Voyager Capital
Seattle, United States · 152 deals
OVP Venture Partners
Seattle, United States · 115 deals
Washington Research Foundation
Seattle, United States · 54 deals
Second Avenue Partners
Seattle, United States · 43 deals